Linked Life Data

20809335

Source:http://linkedlifedata.com/resource/pubmed/id/20809335

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2010-9-29
pubmed:abstractText
Over the last decade, understanding of glioma on a molecular level has greatly expanded. However, optimal incorporation of molecular markers into clinical care is controversial. We briefly review the potential utility of molecular stratification in refining histologic diagnosis, prognosis, and treatment decisions, focussing on 1p/19q co-deletion, MGMT promoter methylation, EGFR mutations, and IDH mutation. The most recently discovered IDH mutation is a striking example of a rapid implementation of a molecular marker for prognostication into common clinical use.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1776-260X
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
5
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
201-10
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Molecular markers in gliomas: impact for the clinician.
pubmed:affiliation
Department of Oncology, University Hospital Zürich, Zürich, Switzerland. Silvia.Hofer@usz.ch
pubmed:publicationType
Journal Article, Review